Works matching AU Trudel, Suzanne

Results: 67

A Single‐Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities.

Published in:

EJHaem, 2025, v. 6, n. 3, p. 1, doi. 10.1002/jha2.70045

By:

Patel, Ashish;
Masih‐Khan, Esther;
Smith, Adam;
Lajkosz, Katherine;
Bhella, Sita;
Chen, Christine;
Prica, Anca;
Reece, Donna;
Stewart, A. Keith;
Tiedemann, Roger;
Trudel, Suzanne;
Yang, Chloe;
Lancman, Guido;
Kukreti, Vishal

Publication type:

Article

Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.

Published in:

European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x

By:

Zangari, Maurizio;
Aujay, Monette;
Fenghuang Zhan;
Hetherington, Kristina L.;
Berno, Tamara;
Vij, Ravi;
Jagannath, Sundar;
Siegel, David;
Stewart, A. Keith;
Wang, Luhua;
Orlowski, Robert Z.;
Belch, Andrew;
Jakubowiak, Andrzej;
Somlo, George;
Trudel, Suzanne;
Bahlis, Nizar;
Lonial, Sagar;
Singhal, Seema;
Kukreti, Vishal;
Tricot, Guido

Publication type:

Article

Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.

Published in:

2012

By:

Jimenez-Zepeda, Victor;
Vajpeyi, Rajkumar;
John, Rohan;
Trudel, Suzanne

Publication type:

Report

Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.

Published in:

American Journal of Hematology, 2014, v. 89, n. 4, p. 363, doi. 10.1002/ajh.23640

By:

Minden, Mark D.;
Hogge, Donna E.;
Weir, Scott J.;
Kasper, Jim;
Webster, Debra A.;
Patton, Lavonne;
Jitkova, Yulia;
Hurren, Rose;
Gronda, Marcela;
Goard, Carolyn A.;
Rajewski, Lian G.;
Haslam, John L.;
Heppert, Kathleen E.;
Schorno, Kevin;
Chang, Hong;
Brandwein, Joseph M.;
Gupta, Vikas;
Schuh, Andre C.;
Trudel, Suzanne;
Yee, Karen W. L.

Publication type:

Article

Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Published in:

American Journal of Hematology, 2013, v. 88, n. 4, p. 337, doi. 10.1002/ajh.23394

By:

Kukreti, Vishal;
Masih-Khan, Esther;
Young, Trieu;
Chu, Chia-Min;
Jiang, Haiyun;
Trudel, Suzanne;
Chen, Christine;
Jimenez-Zepeda, Victor;
Reece, Donna E.

Publication type:

Article

Autologous stem cell transplant for light chain deposition disease: Incorporating bortezomib to the induction therapy.

Published in:

American Journal of Hematology, 2012, v. 87, n. 8, p. 822, doi. 10.1002/ajh.23235

By:

Jimenez-Zepeda, Victor H.;
Trudel, Suzanne;
Winter, Andrew;
Reece, Donna E.;
Chen,, Christine;
Kukreti, Vishal

Publication type:

Article

Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation.

Published in:

American Journal of Hematology, 2011, v. 86, n. 10, p. 873, doi. 10.1002/ajh.22115

By:

Jimenez-Zepeda, Victor H.;
Trudel, Suzanne;
Reece, Donna E.;
Chen, Christine;
Rabea, Ahmed M.;
Kukreti, Vishal

Publication type:

Article

Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.

Published in:

Life Science Alliance, 2023, v. 6, n. 1, p. 1, doi. 10.26508/lsa.202201543

By:

Chow, Signy;
Kis, Olena;
Mulder, David T.;
Danesh, Arnavaz;
Bruce, Jeff;
Wang, Ting Ting;
Reece, Donna;
Bhalis, Nizar;
Neri, Paola;
Sabatini, Peter J. B.;
Keats, Jonathan;
Trudel, Suzanne;
Pugh, Trevor J.

Publication type:

Article

Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patients.

Published in:

Cancer Medicine, 2017, v. 6, n. 1, p. 3, doi. 10.1002/cam4.799

By:

Kotchetkov, Rouslan;
Masih‐Khan, Esther;
Chu, Chia‐Min;
Atenafu, Eshetu G.;
Chen, Christine;
Kukreti, Vishal;
Trudel, Suzanne;
Tiedemann, Rodger;
Reece, Donna E.

Publication type:

Article

Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01135-2

By:

McCurdy, Arleigh;
Reece, Donna;
Louzada, Martha L.;
White, Darrell;
Parkin, Stephen;
Chu, Michael P.;
Kotb, Rami;
Mian, Hira;
Othman, Ibraheem;
Su, Jiandong;
Khan, Aniba;
Gul, Engin;
Trudel, Suzanne

Publication type:

Article

Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26598-w

By:

Croucher, Danielle C.;
Richards, Laura M.;
Tsofack, Serges P.;
Waller, Daniel;
Li, Zhihua;
Wei, Ellen Nong;
Huang, Xian Fang;
Chesi, Marta;
Bergsagel, P. Leif;
Sebag, Michael;
Pugh, Trevor J.;
Trudel, Suzanne

Publication type:

Article

An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 867, doi. 10.1007/s00280-013-2078-0

By:

De, Pradip;
Dey, Nandini;
Terakedis, Breanne;
Bergsagel, P.;
Li, Zhi;
Mahadevan, Daruka;
Garlich, Joseph;
Trudel, Suzanne;
Makale, Milan;
Durden, Donald

Publication type:

Article

P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970512.51896.93

By:

Vesole, David H.;
Berdeja, Jesus;
Matous, Jeffrey;
Trudel, Suzanne;
Schade, Henning;
Munster, Pamela;
Berkeley, Savannah;
Sun, Benjamin;
Martin, Tom

Publication type:

Article

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE‐EXPANSION PHASE OF THE CC‐92480‐MM‐001 TRIAL.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970376.71405.63

By:

Bahlis, Nizar J;
Trudel, Suzanne;
Quach, Hang;
Popat, Rakesh;
Lonial, Sagar;
Orlowski, Robert Z;
Kim, Kihyun;
Mateos, Maria‐Victoria;
Pawlyn, Charlotte;
Ramasamy, Karthik;
Martinez‐Lopez, Joaquín;
Casas‐Avilés, Ignacio;
Spirli, Alessia;
Gong, Jing;
Amatangelo, Michael;
Katz, Jessica;
Maciag, Paulo;
Peluso, Teresa;
Richardson, Paul

Publication type:

Article

P946: TOCILIZUMAB PRE-TREATMENT SIGNIFICANTLY REDUCES THE INCIDENCE OF CYTOKINE RELEASE SYNDROME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE CEVOSTAMAB.

Published in:

2023

By:

Mateos, Maria-Victoria;
Bahlis, Nizar J;
Spencer, Andrew;
Kaedbey, Rayan;
Rodríguez-Otero, Paula;
Harrison, Simon;
Wong, Chihunt;
Goodman, Grant;
Nakamura, Rin;
Choeurng, Voleak;
Cooper, James;
Trudel, Suzanne

Publication type:

Abstract

A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2021, v. 62, n. 7, p. 1721, doi. 10.1080/10428194.2021.1876864

By:

Khan, Sahar;
LeBlanc, Richard;
Gyger, Martin;
White, Darrell;
Kaufman, Johnathan;
Jazubowiak, Andrzej;
Gul, Engin;
Paul, Harminder;
Le, Lisa W.;
Lau, Anthea;
Li, Zhihua;
Trudel, Suzanne

Publication type:

Article

Syngeneic transplants for multiple myeloma – a single center experience and review of the literature.

Published in:

2020

By:

Lebel, Eyal;
Prica, Anca;
Bhella, Sita;
Kukreti, Vishal;
Tiedemann, Rodger;
Trudel, Suzanne;
Reece, Donna;
Chen, Christine

Publication type:

Letter

An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 8, p. 1860, doi. 10.1080/10428194.2020.1747064

By:

Chen, Christine I.;
Cao, Yanshuo;
Trudel, Suzanne;
Reece, Donna E.;
Kukreti, Vishal;
Tiedemann, Rodger;
Prica, Anca;
Paul, Harminder;
Le, Lisa W.;
Levina, Olga;
Kakar, Sumeet;
Lau, Anthea;
Chen, Hongzhuan;
Chen, Eric

Publication type:

Article

A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL).

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 980, doi. 10.1080/10428194.2018.1508669

By:

Chen, Christine I.;
Paul, Harminder;
Snitzler, Susi;
Kakar, Sumeet;
Le, Lisa W.;
Wei, Ellen N.;
Lau, Anthea;
Johnston, James B.;
Gibson, Spencer B.;
Queau, Michelle;
Spaner, David;
Croucher, Danielle;
Sherry, Barbara;
Trudel, Suzanne

Publication type:

Article

A phase 2 study of ofatumumab (Arzerra<sup>®</sup>) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 1, p. 92, doi. 10.1080/10428194.2018.1468892

By:

Chen, Christine I.;
Paul, Harminder;
Le, Lisa W.;
Wei, Ellen N.;
Snitzler, Susi;
Wang, Trina;
Levina, Olga;
Kakar, Sumeet;
Lau, Anthea;
Queau, Michelle;
Johnston, James B.;
Smith, Deborah A.;
Trudel, Suzanne

Publication type:

Article

Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 9, p. 2668, doi. 10.3109/10428194.2014.1003057

By:

Jimenez-Zepeda, Victor H.;
Reece, Donna E.;
Trudel, Suzanne;
Chen, Christine;
Franke, Norman;
Winter, Andrew;
Tiedemann, Rodger;
Kukreti, Vishal

Publication type:

Article

Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 407, doi. 10.3109/10428194.2014.915544

By:

Sun, Haowei (Linda);
Atenafu, Eshetu G.;
Yeboah, Elizabeth;
Reece, Donna E.;
Trudel, Suzanne;
Kukreti, Vishal;
Masih-Khan, Esther;
Winter, Andrew;
Chen, Christine

Publication type:

Article

Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia.

Published in:

2015

By:

Jimenez-Zepeda, Victor H.;
Reece, Donna E.;
Trudel, Suzanne;
Chen, Christine;
Tiedemann, Rodger;
Kukreti, Vishal

Publication type:

Letter to the Editor

Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 10, p. 2284, doi. 10.3109/10428194.2013.873537

By:

Jimenez-Zepeda, Victor H.;
Reece, Donna E.;
Trudel, Suzanne;
Franke, Norman;
Winter, Andrew;
Chen, Christine;
Tiedemann, Rodger;
Kukreti, Vishal

Publication type:

Article

Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2013, v. 54, n. 3, p. 555, doi. 10.3109/10428194.2012.719614

By:

Jimenez-Zepeda, Victor H.;
Reece, Donna E.;
Trudel, Suzanne;
Chen, Christine;
Tiedemann, Rodger;
Kukreti, Vishal

Publication type:

Article

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.

Published in:

Cancer (0008543X), 2024, v. 130, n. 15, p. 2629, doi. 10.1002/cncr.35319

By:

Suvannasankha, Attaya;
Bahlis, Nizar;
Trudel, Suzanne;
Weisel, Katja;
Koenecke, Christian;
Oriol, Albert;
Voorhees, Peter M.;
Alonso, Aranzazu A.;
Callander, Natalie S.;
Mateos, María‐Victoria;
Reddy, Nishitha;
Hakim, Shawn;
LaMacchia, John;
Patel, Nashita;
Williams, Danaé;
Jewell, Roxanne C.;
Zhou, Xiangdong;
Gupta, Ira;
Opalinska, Joanna;
Nooka, Ajay K.

Publication type:

Article

Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.

Published in:

Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987

By:

Nooka, Ajay K.;
Cohen, Adam D.;
Lee, Hans C.;
Badros, Ashraf;
Suvannasankha, Attaya;
Callander, Natalie;
Abdallah, Al‐Ola;
Trudel, Suzanne;
Chari, Ajai;
Libby, Edward N.;
Chaudhry, Maria;
Hultcrantz, Malin;
Kortüm, K. Martin;
Popat, Rakesh;
Sborov, Douglas;
Hakim, Shawn;
Lewis, Eric;
Gorsh, Boris;
Bhushan, Bharat;
McKeown, Astrid

Publication type:

Article

Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma.

Published in:

British Journal of Haematology, 2014, v. 165, n. 5, p. 1, doi. 10.1111/bjh.13004

By:

Reeder, Craig B.;
Reece, Donna E.;
Kukreti, Vishal;
Mikhael, Joseph R.;
Chen, Christine;
Trudel, Suzanne;
Laumann, Kristina;
Vohra, Harjot;
Fonseca, Rafael;
Bergsagel, P. Leif;
Leis, Jose F.;
Tiedemann, Rodger;
Stewart, A. Keith

Publication type:

Article

Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2014, v. 165, n. 5, p. 731, doi. 10.1111/bjh.12785

By:

Chen, Christine I.;
Paul, Harminder;
Wang, Trina;
Le, Lisa W.;
Dave, Nimisha;
Kukreti, Vishal;
Nong Wei, Ellen;
Lau, Anthea;
Bergsagel, Peter Leif;
Trudel, Suzanne

Publication type:

Article

Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution.

Published in:

British Journal of Haematology, 2014, v. 164, n. 5, p. 722, doi. 10.1111/bjh.12673

By:

Jimenez‐Zepeda, Victor H.;
Franke, Norman;
Reece, Donna E.;
Trudel, Suzanne;
Chen, Christine;
Delgado, Diego H.;
Winter, Andrew;
Mikhael, Joseph R.;
Tiedemann, Rodger;
Kukreti, Vishal

Publication type:

Article

Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.

Published in:

British Journal of Haematology, 2013, v. 162, n. 4, p. 483, doi. 10.1111/bjh.12414

By:

Chen, Christine I.;
Masih‐Khan, Esther;
Jiang, Haiyan;
Rabea, Ahmed;
Cserti‐Gazdewich, Christine;
Jimenez‐Zepeda, Victor H.;
Chu, Chia‐Min;
Kukreti, Vishal;
Trudel, Suzanne;
Tiedemann, Rodger;
Tsang, Richard;
Reece, Donna E.

Publication type:

Article

D(T) PACE as salvage therapy for aggressive or refractory multiple myeloma.

Published in:

British Journal of Haematology, 2013, v. 161, n. 6, p. 802, doi. 10.1111/bjh.12325

By:

Gerrie, Alina S.;
Mikhael, Joseph R.;
Cheng, Lu;
Jiang, Haiyan;
Kukreti, Vishal;
Panzarella, Tony;
Reece, Donna;
Stewart, Keith A.;
Trieu, Young;
Trudel, Suzanne;
Chen, Christine I.

Publication type:

Article

research paper Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma.

Published in:

British Journal of Haematology, 2004, v. 124, n. 5, p. 595, doi. 10.1111/j.1365-2141.2004.04814.x

By:

Peterson, Joshua L.;
Zhihua Li;
Xiao-Yan Wen, Joshua L.;
Masih-Khan, Esther;
Hong Chang;
Pollett, Jonathan B.;
Trudel, Suzanne;
Stewart, A. Keith

Publication type:

Article

Differential regulation of FGFR3 by PTPN1 and PTPN2.

Published in:

Proteomics, 2015, v. 15, n. 2/3, p. 419, doi. 10.1002/pmic.201400259

By:

St‐Germain, Jonathan R.;
Taylor, Paul;
Zhang, Wen;
Li, Zhihua;
Ketela, Troy;
Moffat, Jason;
Neel, Benjamin G.;
Trudel, Suzanne;
Moran, Michael F.

Publication type:

Article

Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.

Published in:

Cold Spring Harbor Molecular Case Studies, 2023, v. 9, n. 2, p. 1, doi. 10.1101/mcs.a006249

By:

Croucher, Danielle C.;
Devasia, Anup Joseph;
Abelman, D.;
Mahdipour-Shirayeh, Ali;
Zhihua Li;
Erdmann, Natalie;
Tiedemann, Rodger;
Pugh, Trevor J.;
Trudel, Suzanne

Publication type:

Article

Fixed duration vs. prolonged duration treatment after first line therapy in patients with systemic light chain amyloidosis.

Published in:

Amyloid, 2022, v. 29, n. 1, p. 23, doi. 10.1080/13506129.2021.1978423

By:

Rivera Duarte, Alfonso;
Reece, Donna;
Li, Xuan;
Xu, Wei;
Paul, Harminder;
Masih-Khan, Esther;
Winter, Andrew;
Tiedemann, Rodger;
Prica, Anca;
Chen, Christine;
Trudel, Suzanne;
Kukreti, Vishal

Publication type:

Article

Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3mL per injection site.

Published in:

Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 4, p. 285, doi. 10.1177/1078155214533367

By:

Ng, Pamela;
Incekol, Diana;
Lee, Roy;
Paisley, Emma;
Dara, Celina;
Brandle, Ian;
Kaufman, Marina;
Chen, Christine;
Trudel, Suzanne;
Tiedemann, Rodger;
Reece, Donna;
Kukreti, Vishal

Publication type:

Article

Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Published in:

Nature Communications, 2017, v. 8, n. 5, p. 15086, doi. 10.1038/ncomms15086

By:

Kis, Olena;
Kaedbey, Rayan;
Chow, Signy;
Danesh, Arnavaz;
Dowar, Mark;
Li, Tiantian;
Li, Zhihua;
Liu, Jessica;
Mansour, Mark;
Masih-Khan, Esther;
Zhang, Tong;
Bratman, Scott V.;
Oza, Amit M.;
Kamel-Reid, Suzanne;
Trudel, Suzanne;
Pugh, Trevor J.

Publication type:

Article

Antagonism of the Stat3-Stat3 Protein Dimer with Salicylic Acid Based Small Molecules.

Published in:

ChemMedChem, 2011, v. 6, n. 8, p. 1459, doi. 10.1002/cmdc.201100194

By:

Fletcher, Steven;
Page, Brent D. G.;
Zhang, Xialoei;
Yue, Peibin;
Li, Zhi Hua;
Sharmeen, Sumaiya;
Singh, Jagdeep;
Zhao, Wei;
Schimmer, Aaron D.;
Trudel, Suzanne;
Turkson, James;
Gunning, Patrick T.

Publication type:

Article

Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study.

Published in:

Cancer (0008543X), 2021, v. 127, n. 22, p. 4198, doi. 10.1002/cncr.33809

By:

Lonial, Sagar;
Lee, Hans C.;
Badros, Ashraf;
Trudel, Suzanne;
Nooka, Ajay K.;
Chari, Ajai;
Abdallah, Al‐Ola;
Callander, Natalie;
Sborov, Douglas;
Suvannasankha, Attaya;
Weisel, Katja;
Voorhees, Peter M.;
Womersley, Lynsey;
Baron, January;
Piontek, Trisha;
Lewis, Eric;
Opalinska, Joanna;
Gupta, Ira;
Cohen, Adam D.

Publication type:

Article

Phase I- II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma.

Published in:

British Journal of Haematology, 2015, v. 168, n. 1, p. 46, doi. 10.1111/bjh.13100

By:

Reece, Donna E.;
Masih‐Khan, Esther;
Atenafu, Eshetu G.;
Jimenez‐Zepeda, Victor H.;
Anglin, Peter;
Chen, Christine;
Kukreti, Vishal;
Mikhael, Joseph R.;
Trudel, Suzanne

Publication type:

Article

Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma.

Published in:

British Journal of Haematology, 2014, v. 167, n. 4, p. 563, doi. 10.1111/bjh.13004

By:

Reeder, Craig B.;
Reece, Donna E.;
Kukreti, Vishal;
Mikhael, Joseph R.;
Chen, Christine;
Trudel, Suzanne;
Laumann, Kristina;
Vohra, Harjot;
Fonseca, Rafael;
Bergsagel, P. Leif;
Leis, Jose F.;
Tiedemann, Rodger;
Stewart, A. Keith

Publication type:

Article

Effect of Noncompetitive Proteasome Inhibition on Bortezomib Resistance.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 14, p. 1069, doi. 10.1093/jnci/djq198

By:

Xiaoming Li;
Wood, Tabitha E.;
Sprangers, Remco;
Jansen, Gerrit;
Franke, Niels E.;
Xinliang Mao;
Xiaoming Wang;
Yi Zhang;
Verbrugge, Sue Ellen;
Adomat, Hans;
Zhi Hua Li;
Trudel, Suzanne;
Chen, Christine;
Religa, Tomasz L.;
Jamal, Nazir;
Messner, Hans;
Cloos, Jacqueline;
Rose, David R.;
Navon, Ami;
Guns, Emma

Publication type:

Article

Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in Canada.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 6, p. e404, doi. 10.1016/j.clml.2025.01.010

By:

Mian, Hira S.;
Visram, Alissa;
Shih, Steven Chun-Min;
Trudel, Suzanne;
Hay, Annette E.;
LeBlanc, Richard;
Sebag, Michael;
Kaedbey, Rayan;
Stakiw, Julie;
Sandhu, Irwindeep;
Phua, Chai W.;
Kuruvilla, Philip G.;
Othman, Ibraheem;
Quest, Graeme;
McMullen, David;
Colasurdo, Gabriele;
Kotb, Rami;
Venner, Christopher P.

Publication type:

Article

The Impact of CD34<sup>+</sup> Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 850, doi. 10.1016/j.clml.2023.07.014

By:

Lebel, Eyal;
Lajkosz, Katherine;
Masih-Khan, Esther;
Reece, Donna;
Trudel, Suzanne;
Tiedemann, Rodger;
Prica, Anca;
Kukreti, Vishal;
Chen, Christine

Publication type:

Article

Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. e97, doi. 10.1016/j.clml.2022.11.007

By:

Khan, Sahar;
Reece, Donna;
Atenafu, Eshetu G.;
Bhella, Sita;
Chen, Christine;
Masih-Khan, Esther;
Paul, Harminder;
Prica, Anca;
Tiedemann, Rodger;
Trudel, Suzanne;
Kukreti, Vishal

Publication type:

Article

P-222: Extended follow-up safety and efficacy results of Belantamab mafodotin (Belamaf) 1.92 mg/kg or 2.5 mg/kg combined with POM and DEX for the treatment of relapsed/refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S162, doi. 10.1016/S2152-2650(21)02349-1

By:

Trudel, Suzanne;
McCurdy, Arleigh;
Sutherland, Heather;
Louzada, Martha;
Venner, Christopher;
White, Darrell;
Hira Mian;
Kotb, Rami;
Othman, Ibraheem;
Camacho, Fernando;
Molei Fu;
Engin Gul;
Reece, Donna

Publication type:

Article

P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S160, doi. 10.1016/S2152-2650(21)02346-6

By:

Terpos, Evangelos;
Badros, Ashraf Z.;
Popat, Rakesh;
Rodríguez-Otero, Paula;
Farooq, Asim V.;
Jeng, Bennie;
Esposti, Simona Degli;
Lewis, Eric;
Gupta, Ira;
Opalinska, Joanna;
Palumbo, Antonio;
Trudel, Suzanne;
Jadhav, Vinay

Publication type:

Article

P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)02339-9

By:

Richardson, Paul G.;
Trudel, Suzanne;
Callander, Natalie S.;
Nooka, Ajay;
Song, Kevin;
Uttervall, Katarina;
Minnema, Monique C.;
Rodríguez-Otero, Paula;
Struemper, Herbert;
Yeakey, Anne;
de Oca, Rocio Montes;
Smith, L. Mary;
Jackson, Nicola;
Kaisermann, Morrys;
Im, Ellie;
Basile, Frank G.;
Ahlers, Christoph M.;
Holkova, Beata;
Gupta, Ira;
Kremer, Brandon E.

Publication type:

Article

P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S139, doi. 10.1016/S2152-2650(21)02314-4

By:

Ayers, Dieter;
Cope, Shannon;
Dhanda, Devender S.;
Towle, Kevin;
Mojebi, Ali;
Delforge, Michel;
Rodríguez-Otero, Paula;
Trudel, Suzanne;
Weisel, Katja;
Zamagni, Elena;
Hari, Parameswaran

Publication type:

Article